Table 6. rad9Δ instabilities using different chemical growth media.
Genotype | Unstable Chr. (×10−5) | Allelic rec. (×10−5) | Chr. loss (×10−4) | ||||
---|---|---|---|---|---|---|---|
Median (Q1, Q3) | Fold stabil. | Median (Q1, Q3) | Fold stabil. | Median (Q1, Q3) | Fold stabil. | ||
rad9Δ | 57 (40, 71) | 1 | 6.0 (2.8, 8.2) | 1 | 22 (16, 39) | 1 | |
Cycloheximide | rad9Δ 0.04 μg/ml cyc. | 78 (67, 99) | 0.73 | 8.4 (4.6, 12) | 0.71 | 47 (28, 57) | 0.47 |
rad9Δ 0.06 μg/ml cyc. | 86 (67, 97) | 0.66 | 6.4 (3.1, 12) | 0.94 | 36 (19, 53) | 0.61 | |
D-glucosamine | rad9Δ 2% Dex, 0.2% D-gluc | 62 (54, 90) | 0.92 | 2.2 (1.1, 4.8) | 2.7 | 6.9 (6.0, 8.2) | 3.2* |
rad9Δ 2% Dex, 0.7% D-gluc | 72 (43, 130) | 0.79 | 9.0 (8.1, 9.3) | 0.67 | 11 (7.1, 16) | 2.0 | |
rad9Δ 2% Dex, 1.0% D-gluc | 33 (23, 42) | 1.7 | 1.1 (0.28, 4.3) | 5.5* | 30 (14, 51) | 0.73 | |
rad9Δ 2% Dex, 1.8% D-gluc | 27 (19, 30) | 2.1* | 3.3 (2.2, 5.9) | 1.8 | 14 (8.8, 19) | 1.6 | |
Myriocin | rad9Δ 800 ng/ml myriocin | 59 (52, 71) | 0.97 | 7.0 (4.7, 10) | 0.86 | 10 (8.7, 16) | 2.2* |
rad9Δ 1000 ng/ml myriocin | 43 (36, 50) | 1.3 | 2.2 (1.4, 3.0) | 2.7* | 5.8 (4.9, 8.1) | 3.8* | |
NaCl | rad9Δ 0.125 M NaCla | 33 (27, 36) | 1.7 | 2.5 (2.0, 7.5) | 2.4 | 21 (12, 27) | 1.00 |
rad9Δ 0.25 M NaCla | 44 (34, 55) | 1.3 | 13 (11, 17) | 0.46* | 92 (60, 105) | 0.24 | |
rad9Δ 0.5 M NaCla | 47 (35, 54) | 1.2 | 12 (10, 14) | 0.50* | 76 (67, 130) | 0.30* | |
rad9Δ 1.0 M NaCla | 120 (94, 180) | 0.48* | 9.0 (5.5, 23) | 0.67 | 4900 (3900, 6300) | 0.0045* | |
YEPG | rad9Δ 2% glycerolb | 29 (15, 31) | 2.0 | 2.5 (1.4, 6.1) | 2.4 | 710 (350, 810) | 0.031* |
Instability frequencies and genome fold stabilization of rad9Δ grown on media plates containing various concentrations of cycloheximide (protein synthesis inhibitor), D-glucosamine (glucose competitor), myriocin (sphingolipid inhibitor), NaCl (osmotic stress inducer), and YEPG (glycerol, respiration energy source) normalized to rad9Δ grown on YEPD media plates. Cells with a light gray background indicate genome fold stabilization increase; cells with a white background indicate decreased fold stabilization (<1.0 = increased instability) or no change in stabilization (=1.0). Statistically significant appears in boldface type. Kruskal–Wallis test, * P < 0.01.
Viability not tested.
Sample size: N = 5.